Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from Numinus Wellness ( (TSE:NUMI) ) is now available.
Numinus Wellness Inc. announced a change in its Chief Financial Officer position, with Kelvin Yang stepping in as the Interim CFO effective February 18, 2025, replacing Melony Valleau. This transition, approved by the Board of Directors, aligns with Numinus’s ongoing strategic initiatives and is expected to support the company’s regulatory and compliance efforts as it continues to pursue its corporate planning objectives.
More about Numinus Wellness
Numinus Wellness Inc. is a mental healthcare company that focuses on advancing both traditional and innovative behavioral health treatments. The company specializes in safe, evidence-based psychedelic-assisted therapies aimed at healing conditions such as depression, anxiety, trauma, pain, and substance use. Numinus is committed to integrating these therapies into mainstream clinical practices through technology-driven clinic support, clinical trial research, and comprehensive practitioner training.
YTD Price Performance: 7.50%
Average Trading Volume: 311,699
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$13.86M
See more insights into NUMI stock on TipRanks’ Stock Analysis page.
